Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02949362 · ClinicalTrials.gov registry record · Phase 3
Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
A Phase 3 study, sponsored by Shire.
- Completed
- Registry status
- Phase 3
- Development phase
- 29
- Enrollment target
NCT02949362 is a Phase 3 study that has completed, run by Shire. The registered enrollment target is 29 participants.
The verdict
NCT02949362, a Phase 3 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of teduglutide treatment of children with short bowel syndrome (SBS) who completed the TED-C13-003 study over a long-term period. It will evaluate how these children fared after the TED-C13-003 study ended. This study will also offer teduglutide treatment to eligible subjects, regardless of treatment received in TED-C13-003.
Interventions
- OTHER SOC
- DRUG Teduglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-12-09 |
| Est. Completion | 2020-07-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02949362
The ClinicalTrials.gov registry entry for NCT02949362 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SOC is the first listed.
NCT02949362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02949362 about?
NCT02949362 is a clinical study titled "Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study". The purpose of this study is to evaluate the safety and efficacy of teduglutide treatment of children with short bowel syndrome (SBS) who completed the TED-C13-003 study over a long-term period. It will evaluate how these children fared after the TED-C13-003 study ended. This study will also offer t...
What is the current status of trial NCT02949362?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 29 participants. The study started on 2016-12-09. Estimated completion is 2020-07-14.
What interventions are being tested in trial NCT02949362?
The interventions under investigation include: SOC (OTHER), Teduglutide (DRUG).
Who is sponsoring clinical trial NCT02949362?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.